To fully understand the key molecular event in the pathogenesis of prion diseases, the structural conversion of PrP, generation of a soluble monomeric recombinant PrPC in Escherichia coli that can be used for monitoring conformational conversion in vitro has been one of the important steps. This evidence concerns the gene PRNP and prion disease.